<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04095234</url>
  </required_header>
  <id_info>
    <org_study_id>19-341</org_study_id>
    <nct_id>NCT04095234</nct_id>
  </id_info>
  <brief_title>Integrative Medicine for Pain in Patients With Advanced Cancer Trial (IMPACT)</brief_title>
  <official_title>Integrative Medicine for Pain in Patients With Advanced Cancer Trial (IMPACT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Memorial Sloan Kettering Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Memorial Sloan Kettering Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the long-term effectiveness of acupuncture versus
      massage in people living with advanced cancer. The study will test how the two approaches
      compare in helping people with pain and its related symptoms and improving quality of life.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 17, 2019</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Two-arm parallel (Acupuncture vs. Massage) randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Worst Pain</measure>
    <time_frame>26 weeks from randomization</time_frame>
    <description>Worst Pain Item from the short-form Brief Pain Inventory (BPI). The short-form BPI will be used to quantify pain severity and pain interference. The BPI contains 4 pain severity items and 7 pain interference items, all rated on a scale from 0 to 10 (higher ratings indicate worse pain intensity/interference).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Cancer Pain</condition>
  <arm_group>
    <arm_group_label>Acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive up to 10 treatments in the first 10 weeks (+/- 4 days) and then receive monthly booster treatments (+/- 7 days) for up to 26 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Massage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive up to 10 treatments in the first 10 weeks (+/- 4 days) and then receive monthly booster treatments (+/- 7 days) for up to 26 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>Acupuncture, a therapy of traditional Chinese medicine (TCM), involves penetrating the skin with thin, solid, metallic needles that are manipulated by hand or electrical stimulation.</description>
    <arm_group_label>Acupuncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Massage</intervention_name>
    <description>Massage, which involves the manual manipulation of muscles and other soft tissue areas of the body, is one of the earliest known forms of pain relief.</description>
    <arm_group_label>Massage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years or older

          -  Having a diagnosis of the following: stage III or IV lung cancer; any stage pancreatic
             cancer; unresectable cholangiocarcinoma; unresectable liver cancer; unresectable
             ampullary or peri-ampullary cancer or other stage IV gastrointestinal cancer; stage
             III or IV ovarian or fallopian tube cancers or other stage IV gynecologic cancer;
             stage IV breast cancer; stage IV genitourinary cancer; stage III or IV sarcoma; stage
             IV melanoma; stage III or IV head/neck cancer; or stage IV endocrine cancer

          -  Be ambulatory (Karnofsky functional score of ≥ 60)

          -  Having musculoskeletal pain, defined as regional (joints, extremities, back, neck) or
             more generalized (fibromyalgia or chronic widespread pain); Patients with a
             neuropathic component to their pain that involves the extremities or back will be
             eligible.

          -  Having musculoskeletal pain for at least 1 month

          -  Having had pain for at least 15 days in the preceding 30 days

          -  Having a pain rating of 4 or greater in worst pain on a 0-10 numerical rating scale in
             the preceding week

          -  Having an expected prognosis of greater than six months as judged by the treating
             oncologist or study physician

        Exclusion Criteria:

          -  Having a platelet count &lt;15,000

          -  Cognitive impairment precluding response to study assessments

          -  Unwilling to accept random assignment

          -  Unwilling to commit to the 26-week study time period

          -  Have non-musculoskeletal pain syndromes (headache, facial pain, chest pain, visceral
             abdominal pain) if these are the sole source of pain but can be present as co-morbid
             conditions as long as a patient has a primary musculoskeletal pain condition defined
             as above.

          -  Having an implanted electronically charged medical device
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jun J Mao, MD, MSCE</last_name>
    <role>Principal Investigator</role>
    <affiliation>Memorial Sloan Kettering Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jun J Mao, MD, MSCE</last_name>
    <phone>646-888-0866</phone>
    <email>maoj@mskcc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gary Deng, MD, PhD</last_name>
    <phone>646-888-0841</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jun J Mao, MD,MSCE</last_name>
      <phone>646-888-0808</phone>
    </contact>
    <contact_backup>
      <last_name>Gary Deng, MD, PhD</last_name>
      <phone>646-888-0841</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mskcc.org/mskcc/html/44.cfm</url>
    <description>Memorial Sloan Kettering Cancer Center</description>
  </link>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 17, 2019</study_first_submitted>
  <study_first_submitted_qc>September 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 19, 2019</study_first_posted>
  <last_update_submitted>January 13, 2020</last_update_submitted>
  <last_update_submitted_qc>January 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>acupuncture</keyword>
  <keyword>massage</keyword>
  <keyword>IMPACT</keyword>
  <keyword>19-341</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cancer Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

